146 related articles for article (PubMed ID: 3729496)
1. [Induction of mouse peritoneal cytotoxic factor by OK-432. (3). Comparison between LPS and OK-432 as eliciting agents].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Nishii Y; Suzuki S; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2419-24. PubMed ID: 3729496
[TBL] [Abstract][Full Text] [Related]
2. [Induction of a cytotoxic factor into the peritoneal fluid (PCF) by OK-432. II. Physicochemical and immunological characteristics of PCF].
Nagamuta M; Yamamoto A; Usami H; Sugawara Y; Nishii Y; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2358-62. PubMed ID: 3488030
[TBL] [Abstract][Full Text] [Related]
3. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
[TBL] [Abstract][Full Text] [Related]
4. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
[TBL] [Abstract][Full Text] [Related]
5. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
6. Production of cytotoxic factor into mouse peritoneal fluid by OK-432, a streptococcal preparation.
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunol Lett; 1985; 11(2):83-8. PubMed ID: 4086064
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a cytotoxic factor induced in mouse peritoneal fluid by OK-432.
Nagamuta M; Yamamoto A; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunol Lett; 1986 Aug; 13(1-2):101-5. PubMed ID: 3759145
[TBL] [Abstract][Full Text] [Related]
8. [Induction of tumor necrosis factor (TNF) by OK-432].
Watanabe N; Sone H; Neda H; Niitsu Y; Urushizaki I
Gan No Rinsho; 1984 Aug; 30(10):1290-2. PubMed ID: 6481965
[TBL] [Abstract][Full Text] [Related]
9. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
[TBL] [Abstract][Full Text] [Related]
10. Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice.
Satoh M; Shimada Y; Inagawa H; Minagawa H; Kajikawa T; Oshima H; Abe S; Yamazaki M; Mizuno D
Jpn J Cancer Res; 1986 Apr; 77(4):342-4. PubMed ID: 2422147
[TBL] [Abstract][Full Text] [Related]
11. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
12. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
Immunopharmacol Immunotoxicol; 1988; 10(1):53-65. PubMed ID: 3361071
[TBL] [Abstract][Full Text] [Related]
14. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
16. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
Sekimoto M; Kokunai I; Shimano T; Kobayashi T; Takeda T; Haruna N; Yamamoto A; Mori T
J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
[TBL] [Abstract][Full Text] [Related]
17. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
Mori H; Itoh N; Shiraki S; Tamaya T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
[No Abstract] [Full Text] [Related]
18. Impaired induction of type II interferon in tumor-bearing mice.
Matsubara S; Suzuki M; Ishida N
Cancer Res; 1980 Mar; 40(3):873-6. PubMed ID: 6162555
[TBL] [Abstract][Full Text] [Related]
19. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
[TBL] [Abstract][Full Text] [Related]
20. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
